Global Cystic Fibrosis (CF) Therapeutics Market Insights and Forecast to 2028

Report ID: 1802749 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Pancreatic enzyme supplements
        1.2.3 Mucolytics
        1.2.4 Bronchodilators
        1.2.5 CFTR modulators
    1.3 Market by Application
        1.3.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oral drugs
        1.3.3 Inhaled drugs
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cystic Fibrosis (CF) Therapeutics Market Perspective (2017-2028)
    2.2 Cystic Fibrosis (CF) Therapeutics Growth Trends by Region
        2.2.1 Cystic Fibrosis (CF) Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cystic Fibrosis (CF) Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Cystic Fibrosis (CF) Therapeutics Market Dynamics
        2.3.1 Cystic Fibrosis (CF) Therapeutics Industry Trends
        2.3.2 Cystic Fibrosis (CF) Therapeutics Market Drivers
        2.3.3 Cystic Fibrosis (CF) Therapeutics Market Challenges
        2.3.4 Cystic Fibrosis (CF) Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue
        3.1.1 Global Top Cystic Fibrosis (CF) Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Cystic Fibrosis (CF) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cystic Fibrosis (CF) Therapeutics Revenue
    3.4 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio
        3.4.1 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis (CF) Therapeutics Revenue in 2021
    3.5 Cystic Fibrosis (CF) Therapeutics Key Players Head office and Area Served
    3.6 Key Players Cystic Fibrosis (CF) Therapeutics Product Solution and Service
    3.7 Date of Enter into Cystic Fibrosis (CF) Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Type
    4.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2023-2028)
5 Cystic Fibrosis (CF) Therapeutics Breakdown Data by Application
    5.1 Global Cystic Fibrosis (CF) Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cystic Fibrosis (CF) Therapeutics Market Size (2017-2028)
    6.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Type
        6.2.1 North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Cystic Fibrosis (CF) Therapeutics Market Share by Type (2017-2028)
    6.3 North America Cystic Fibrosis (CF) Therapeutics Market Size by Application
        6.3.1 North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Cystic Fibrosis (CF) Therapeutics Market Share by Application (2017-2028)
    6.4 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country
        6.4.1 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size (2017-2028)
    7.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type
        7.2.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Cystic Fibrosis (CF) Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application
        7.3.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Cystic Fibrosis (CF) Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country
        7.4.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size (2017-2028)
    9.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Type
        9.2.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Cystic Fibrosis (CF) Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Application
        9.3.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Cystic Fibrosis (CF) Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country
        9.4.1 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Vertex Pharmaceuticalsorporated
        11.1.1 Vertex Pharmaceuticalsorporated Company Details
        11.1.2 Vertex Pharmaceuticalsorporated Business Overview
        11.1.3 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Introduction
        11.1.4 Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.1.5 Vertex Pharmaceuticalsorporated Recent Developments
    11.2 Gilead
        11.2.1 Gilead Company Details
        11.2.2 Gilead Business Overview
        11.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Introduction
        11.2.4 Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.2.5 Gilead Recent Developments
    11.3 AbbVie,
        11.3.1 AbbVie, Company Details
        11.3.2 AbbVie, Business Overview
        11.3.3 AbbVie, Cystic Fibrosis (CF) Therapeutics Introduction
        11.3.4 AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.3.5 AbbVie, Recent Developments
    11.4 Novartis AG
        11.4.1 Novartis AG Company Details
        11.4.2 Novartis AG Business Overview
        11.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Introduction
        11.4.4 Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.4.5 Novartis AG Recent Developments
    11.5 F. Hoffmann-La Roche Ltd
        11.5.1 F. Hoffmann-La Roche Ltd Company Details
        11.5.2 F. Hoffmann-La Roche Ltd Business Overview
        11.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Introduction
        11.5.4 F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.5.5 F. Hoffmann-La Roche Ltd Recent Developments
    11.6 Alaxia
        11.6.1 Alaxia Company Details
        11.6.2 Alaxia Business Overview
        11.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Introduction
        11.6.4 Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.6.5 Alaxia Recent Developments
    11.7 Merck & Co.
        11.7.1 Merck & Co. Company Details
        11.7.2 Merck & Co. Business Overview
        11.7.3 Merck & Co. Cystic Fibrosis (CF) Therapeutics Introduction
        11.7.4 Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.7.5 Merck & Co. Recent Developments
    11.8 AIT (Advanced Inhalation Therapies)
        11.8.1 AIT (Advanced Inhalation Therapies) Company Details
        11.8.2 AIT (Advanced Inhalation Therapies) Business Overview
        11.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Introduction
        11.8.4 AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.8.5 AIT (Advanced Inhalation Therapies) Recent Developments
    11.9 ALLERGAN
        11.9.1 ALLERGAN Company Details
        11.9.2 ALLERGAN Business Overview
        11.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Introduction
        11.9.4 ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.9.5 ALLERGAN Recent Developments
    11.10 AstraZeneca
        11.10.1 AstraZeneca Company Details
        11.10.2 AstraZeneca Business Overview
        11.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Introduction
        11.10.4 AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.10.5 AstraZeneca Recent Developments
    11.11 Teva Pharmaceutical Industries Ltd
        11.11.1 Teva Pharmaceutical Industries Ltd Company Details
        11.11.2 Teva Pharmaceutical Industries Ltd Business Overview
        11.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Introduction
        11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.11.5 Teva Pharmaceutical Industries Ltd Recent Developments
    11.12 Alcresta
        11.12.1 Alcresta Company Details
        11.12.2 Alcresta Business Overview
        11.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Introduction
        11.12.4 Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
        11.12.5 Alcresta Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Pancreatic enzyme supplements
    Table 3. Key Players of Mucolytics
    Table 4. Key Players of Bronchodilators
    Table 5. Key Players of CFTR modulators
    Table 6. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2017-2022)
    Table 10. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2023-2028)
    Table 12. Cystic Fibrosis (CF) Therapeutics Market Trends
    Table 13. Cystic Fibrosis (CF) Therapeutics Market Drivers
    Table 14. Cystic Fibrosis (CF) Therapeutics Market Challenges
    Table 15. Cystic Fibrosis (CF) Therapeutics Market Restraints
    Table 16. Global Cystic Fibrosis (CF) Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Cystic Fibrosis (CF) Therapeutics Revenue Share by Players (2017-2022)
    Table 18. Global Top Cystic Fibrosis (CF) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2021)
    Table 19. Ranking of Global Top Cystic Fibrosis (CF) Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Cystic Fibrosis (CF) Therapeutics Product Solution and Service
    Table 23. Date of Enter into Cystic Fibrosis (CF) Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2017-2022)
    Table 27. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2023-2028)
    Table 29. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Cystic Fibrosis (CF) Therapeutics Revenue Share by Application (2017-2022)
    Table 31. Global Cystic Fibrosis (CF) Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Cystic Fibrosis (CF) Therapeutics Revenue Share by Application (2023-2028)
    Table 33. North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Vertex Pharmaceuticalsorporated Company Details
    Table 64. Vertex Pharmaceuticalsorporated Business Overview
    Table 65. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Product
    Table 66. Vertex Pharmaceuticalsorporated Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 67. Vertex Pharmaceuticalsorporated Recent Developments
    Table 68. Gilead Company Details
    Table 69. Gilead Business Overview
    Table 70. Gilead Cystic Fibrosis (CF) Therapeutics Product
    Table 71. Gilead Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 72. Gilead Recent Developments
    Table 73. AbbVie, Company Details
    Table 74. AbbVie, Business Overview
    Table 75. AbbVie, Cystic Fibrosis (CF) Therapeutics Product
    Table 76. AbbVie, Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 77. AbbVie, Recent Developments
    Table 78. Novartis AG Company Details
    Table 79. Novartis AG Business Overview
    Table 80. Novartis AG Cystic Fibrosis (CF) Therapeutics Product
    Table 81. Novartis AG Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 82. Novartis AG Recent Developments
    Table 83. F. Hoffmann-La Roche Ltd Company Details
    Table 84. F. Hoffmann-La Roche Ltd Business Overview
    Table 85. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Product
    Table 86. F. Hoffmann-La Roche Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 87. F. Hoffmann-La Roche Ltd Recent Developments
    Table 88. Alaxia Company Details
    Table 89. Alaxia Business Overview
    Table 90. Alaxia Cystic Fibrosis (CF) Therapeutics Product
    Table 91. Alaxia Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 92. Alaxia Recent Developments
    Table 93. Merck & Co. Company Details
    Table 94. Merck & Co. Business Overview
    Table 95. Merck & Co. Cystic Fibrosis (CF) Therapeutics Product
    Table 96. Merck & Co. Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 97. Merck & Co. Recent Developments
    Table 98. AIT (Advanced Inhalation Therapies) Company Details
    Table 99. AIT (Advanced Inhalation Therapies) Business Overview
    Table 100. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product
    Table 101. AIT (Advanced Inhalation Therapies) Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 102. AIT (Advanced Inhalation Therapies) Recent Developments
    Table 103. ALLERGAN Company Details
    Table 104. ALLERGAN Business Overview
    Table 105. ALLERGAN Cystic Fibrosis (CF) Therapeutics Product
    Table 106. ALLERGAN Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 107. ALLERGAN Recent Developments
    Table 108. AstraZeneca Company Details
    Table 109. AstraZeneca Business Overview
    Table 110. AstraZeneca Cystic Fibrosis (CF) Therapeutics Product
    Table 111. AstraZeneca Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 112. AstraZeneca Recent Developments
    Table 113. Teva Pharmaceutical Industries Ltd Company Details
    Table 114. Teva Pharmaceutical Industries Ltd Business Overview
    Table 115. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product
    Table 116. Teva Pharmaceutical Industries Ltd Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 117. Teva Pharmaceutical Industries Ltd Recent Developments
    Table 118. Alcresta Company Details
    Table 119. Alcresta Business Overview
    Table 120. Alcresta Cystic Fibrosis (CF) Therapeutics Product
    Table 121. Alcresta Revenue in Cystic Fibrosis (CF) Therapeutics Business (2017-2022) & (US$ Million)
    Table 122. Alcresta Recent Developments
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cystic Fibrosis (CF) Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Pancreatic enzyme supplements Features
    Figure 3. Mucolytics Features
    Figure 4. Bronchodilators Features
    Figure 5. CFTR modulators Features
    Figure 6. Global Cystic Fibrosis (CF) Therapeutics Market Share by Application: 2021 VS 2028
    Figure 7. Oral drugs Case Studies
    Figure 8. Inhaled drugs Case Studies
    Figure 9. Cystic Fibrosis (CF) Therapeutics Report Years Considered
    Figure 10. Global Cystic Fibrosis (CF) Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Cystic Fibrosis (CF) Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Cystic Fibrosis (CF) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue in 2021
    Figure 16. North America Cystic Fibrosis (CF) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 18. North America Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 19. North America Cystic Fibrosis (CF) Therapeutics Market Size Share by Country (2017-2028)
    Figure 20. United States Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Cystic Fibrosis (CF) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Cystic Fibrosis (CF) Therapeutics Market Size Share by Country (2017-2028)
    Figure 26. Germany Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Cystic Fibrosis (CF) Therapeutics Market Size Share by Region (2017-2028)
    Figure 36. China Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Cystic Fibrosis (CF) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Cystic Fibrosis (CF) Therapeutics Market Size Share by Country (2017-2028)
    Figure 46. Mexico Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Size Share by Country (2017-2028)
    Figure 52. Turkey Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Cystic Fibrosis (CF) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Vertex Pharmaceuticalsorporated Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 56. Gilead Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 57. AbbVie, Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 58. Novartis AG Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 59. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 60. Alaxia Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 61. Merck & Co. Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 62. AIT (Advanced Inhalation Therapies) Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 63. ALLERGAN Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 64. AstraZeneca Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 65. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 66. Alcresta Revenue Growth Rate in Cystic Fibrosis (CF) Therapeutics Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Vertex Pharmaceuticalsorporated
Gilead
AbbVie,
Novartis AG
F. Hoffmann-La Roche Ltd
Alaxia
Merck & Co.
AIT (Advanced Inhalation Therapies)
ALLERGAN
AstraZeneca
Teva Pharmaceutical Industries Ltd
Alcresta
Frequently Asked Questions
Cystic Fibrosis (CF) Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cystic Fibrosis (CF) Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cystic Fibrosis (CF) Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Diabetic Neuropathy

Diabetic Neuropathy market is segmented by players, region (country), by Type and by Application. ... Read More

E-Coli Testing

E-Coli Testing market is segmented by players, region (country), by Type and by Application. Play ... Read More